Dear Sir, L-Carnitine is a nonprotein amino acid that is present in tissues with high energy
requirements such as the skeletal muscle and myocardium. It is also present in large …

Background: Patients on hemodialysis (HD) are known to be at risk of carnitine deficiency.
The aims of this study were to investigate the prevalence of carnitine deficiency in patients …

Mechanisms of impaired fatty acid metabolism may not be the same in nondialysis and
hemodialysis patients. Correlations between the serum‐free carnitine concentration (FC) …

Free carnitine, acylcarnitine and total carnitine serum concentrations have been measured
in chronic renal insufficiency patients under conservative treatment, in patients under regular …

Background: Carnitine deficiency is common in patients on dialysis. Serum free carnitine
concentration is significantly lower in patients on hemodialysis (HD) than in healthy …

Dear Sir, Carnitine is an essential cofactor for the transport of long-chain fatty acids from the
cytosol into the mitochondria [1]. Carnitine deficiency has been suggested to be a factor in …

Carnitine, a small-molecular-weight quarternary amine, is lost from the plasma during
hemodialysis in patients with chronic renal failure. Reports are conflicting concerning …

Carnitine metabolism and the therapeutic use of carnitine has been a major area of interest
in dialysis patients. The purpose of this study was to determine whether any correlations …

BACKGROUND: Serum free carnitine is decreased and serum acylcarnitines are increased
in maintenance hemodialysis (MHD) patients, and the causes for these abnormalities are …

Carnitine has high dialyzability and is often deficient in dialysis patients. This deficiency is
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …